These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28926592)

  • 21. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
    Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
    Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducements by Pharmaceutical Companies: The Elephant in the Room.
    Soans ST
    Indian Pediatr; 2018 Aug; 55(8):649-651. PubMed ID: 30218507
    [No Abstract]   [Full Text] [Related]  

  • 23. [There is no Season for Gifts].
    Lieb K; Koch C
    Dtsch Med Wochenschr; 2017 Dec; 142(25):1949-1953. PubMed ID: 29241283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does growing up with a physician influence the ethics of medical students' relationships with the pharmaceutical industry? The cases of the US and Poland.
    Makowska M
    BMC Med Ethics; 2017 Aug; 18(1):49. PubMed ID: 28797266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beliefs and practices of physicians in Lebanon regarding promotional gifts and interactions with pharmaceutical companies.
    Shaarani I; Hasbini J; Farhat R; Safawi N; Sleiman J; Hammoud AK; Fayad T; Khazaal D; Elkhatib O; Berjaoui H
    East Mediterr Health J; 2024 Feb; 30(2):116-124. PubMed ID: 38491897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care system.
    Grande D; Shea JA; Armstrong K
    J Gen Intern Med; 2012 Mar; 27(3):274-9. PubMed ID: 21671130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethical issues associated with gifts provided to physicians by the pharmaceutical industry.
    Komesaroff PA
    Intern Med J; 2010 May; 40(5):321-2. PubMed ID: 20575991
    [No Abstract]   [Full Text] [Related]  

  • 32. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits.
    Lieb K; Scheurich A
    PLoS One; 2014; 9(10):e110130. PubMed ID: 25330392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2010 Oct; 10(10):11-7. PubMed ID: 20945262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.
    Fadlallah R; Nas H; Naamani D; El-Jardali F; Hammoura I; Al-Khaled L; Brax H; Kahale L; Akl EA
    PLoS One; 2016; 11(8):e0160540. PubMed ID: 27556929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Mitchell PB
    Med J Aust; 2009 Sep; 191(5):273-5. PubMed ID: 19740050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.